Xiaofang Liang

Aug 10, 2024 | dovepress.com | Zhihong Liu |Xiaofang Liang |Yu ZHANG |Wenbo Deng

Back to Journals » Infection and Drug Resistance » Volume 17 Authors Liu Z, Liang X, Zhang Y , Deng W , Wang Y, Lu Z , Liu Q, Wei L Received 10 August 2024Accepted for publication 9 October 2024 Published 21 October 2024Volume 2024:17 Pages 4539—4556 DOI https://doi.org/10.2147/IDR.S490998Checked for plagiarism YesReview by Single anonymous peer reviewPeer reviewer comments 2 Editor who approved publication: Prof.

Nov 2, 2023 | biorxiv.org | Ritu Bohat |Xiaofang Liang |Yanping Chen |Chunyu Xu

AbstractSle1 and Faslpr are two lupus susceptibility loci that lead to manifestations of systemic lupus erythematosus. To evaluate dosage effects of FASlpr in determining cellular and serological phenotypes associated with lupus, we developed a new C57BL/6 (B6) congenic lupus strain, B6.Sle1/Sle1.Faslpr/+ (sle1homo.lprhet) and compared it with B6.Faslpr/lpr (lprhomo), B6.Sle1/Sle1 (sle1homo), and B6.Sle1/Sle1.Faslpr/lpr (sle1homo.lprhomo) strains.